M&A Deal Summary |
|
---|---|
Date | 2008-12-08 |
Target | PML Microbiologicals |
Sector | Life Science |
Buyer(s) | bioMerieux |
Sellers(s) | Pelican Life Sciences Group |
Deal Type | Divestiture |
Deal Value | 30M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1963 |
Sector | Life Science |
Employees | 13,409 |
Revenue | 3.7B EUR (2023) |
bioMerieux is a provider in the field of in vitro diagnostics. bioMerieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy l'Etoile, France.
DEAL STATS | # |
---|---|
Overall | 10 of 21 |
Sector (Life Science) | 7 of 11 |
Type (Divestiture) | 3 of 3 |
State (Oregon) | 1 of 1 |
Country (United States) | 5 of 8 |
Year (2008) | 3 of 3 |
Size (of disclosed) | 6 of 6 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-09-11 |
AviaraDX
San Diego, California, United States AviaraDX, Inc. is a developing and commercializing molecular diagnostic technologies for personalized medicine in cancer treatment. |
Buy | $60M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-01-14 |
Meikang Biotech
Shanghai, China Meikang Biotech (Shanghai) Co., Ltd. is a manufacturer of rapid tests products. |
Buy | - |
Category | Company |
---|---|
Sector | Life Science |
Pelican Life Sciences Group is a provider of diagnostic solutions.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Oregon) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2008) | 1 of 1 |
Size (of disclosed) | 1 of 1 |